Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wingspan Coverage Policy Has Broad Implications For Humanitarian Devices

This article was originally published in The Gray Sheet

Executive Summary

CMS' proposed coverage decision for Boston Scientific's Wingspan intracranial stent has stakeholders on edge about the precedent the agency could set in its first national decision for a humanitarian-use device

You may also be interested in...



Boston Sci’s Wingspan Gets Limited Nat’l Coverage; Broad HDE Policy Will Wait

Medicare will nationally cover intracranial stenting and angioplasty only in the controlled setting of FDA-cleared clinical trials, CMS says

Boston Sci’s Wingspan Gets Limited Nat’l Coverage; Broad HDE Policy Will Wait

Medicare will nationally cover intracranial stenting and angioplasty only in the controlled setting of FDA-cleared clinical trials, CMS says

Neurotechnology Interests Form New Trade Association To Lobby Congress

A newly formed trade association called the Neurotechnology Industry Organization (NIO) will seek greater government support for the development of therapies for brain and nervous system diseases

Related Content

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel